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Research
AbstrACt
Objectives To estimate the prevalence of multimorbidity 
using a list of 75 chronic conditions derived from the 
International Classification for Primary Care, Second 
edition and developed specifically to assess multimorbidity 
in primary care. Our aim was also to provide prevalence 
data for multimorbidity in primary care in a country 
in which general practitioners (GPs) do not play a 
gatekeeping role in the health system.
setting A representative sample of GPs within the Swiss 
Sentinel Surveillance Network.
Participants 118 GPs completed a paper-based 
questionnaire about 25 consecutive patients of all ages 
between September and November 2015. There were no 
patient exclusion criteria. Recorded data included date of 
birth, gender and the patients’ chronic conditions.
Primary and secondary outcome measures We 
estimated the prevalence of multimorbidity, defined as 
≥2, and ≥3 chronic conditions stratified by gender and 
age group, and adjusted for clustering by GPs. We also 
computed the prevalence of each chronic condition 
individually and grouped by system.
results Data from 2904 patients were included (mean 
age (SD)=56.5 (20.5) years; male=43.7%). Prevalence 
was 52.1% (95% CI 48.6% to 55.5%) for ≥2 and 35.0% 
(95% CI 31.6% to 38.5%) for ≥3 chronic conditions, with 
no significant gender differences. Prevalence of two or 
more chronic conditions was low (6.2%, 95% CI 2.8% to 
13.0%) in those below 20 but affected more than 85% 
(85.8%, 95% CI 79.6% to 90.3%) of those above the age 
of 80. The most prevalent conditions were cardiovascular 
(42.7%, 95% CI 39.7% to 45.7%), psychological (28.5%, 
95% CI 26.1% to 31.1%) and metabolic or endocrine 
disorders (24.1%, 95% CI 21.6% to 26.7%). Elevated blood 
pressure was the most prevalent cardiovascular condition 
and depression the most common psychological disorder.
Conclusion In a country in which GPs do not play a 
gatekeeping role within the health system, the prevalence 
of multimorbidity, as assessed using a list of chronic 
conditions specifically relevant to primary care, is high and 
increases with age.
IntrOduCtIOn 
Multimorbidity (MM) is commonly defined 
as the co-occurrence of two, three or more 
chronic conditions (CCs) within one person.1 
Comorbidity in contrast refers to the develop-
ment of conditions in addition to one main 
CC.2 3 The prevalence of MM increases with 
age,4 with an estimated prevalence ranging 
from 20%–30% in the all-ages population to 
55%–98% in individuals over 65 years old.1 
This represents a significant challenge for 
current and future healthcare services. MM 
is most frequently managed in primary care 
(PC) and 70%–80% of the population visits 
a general practitioner (GP) at least once a 
year.5 6 MM constitutes a growing problem in 
view of the ageing population and is also asso-
ciated with increased healthcare costs and 
threats to quality of care.1 
Estimates of the prevalence of MM vary 
significantly depending on various defini-
tions of MM and selected lists with limited 
numbers of CCs, population settings and data 
collection methods.1 3 4 7–10 As a consequence, 
results between studies are difficult to 
compare.11 This was highlighted in 2012 in a 
systematic review of the literature comparing 
strengths and limitations of this study
 ► This study provides estimates of the prevalence of 
multimorbidity based on a sample of patients of all 
ages from representative practices throughout an 
entire European country and using a scientifically 
established list of 75 chronic conditions relevant to 
multimorbidity in primary care.
 ► The list was based on codes from the International 
Classification for Primary Care, Second edition. As 
some common conditions (ie, chronic renal failure) 
are missing from this classification, the reported 
prevalence estimates are somewhat conservative.
 ► Comparisons with previous studies are limited by the 
fact that this is the first time this newly established 
list of chronic conditions relevant to multimorbidity 
was used to provide prevalence estimates.
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studies in PC settings and among the general population 
in different geographical regions.7
In PC, MM is becoming the norm rather than the 
exception and limited lists of CCs are not representa-
tive of daily practice. Yet the number and spread of high 
or low prevalent CCs is so important that for research 
purposes it is important to focus on the CCs that are most 
relevant to MM in PC. Academic investigators developed 
a list of 75 CCs relevant for MM in PC, based on the Inter-
national Classification for Primary Care, Second edition 
(ICPC-2) in a modified RAND method. We believe this is 
yet the best available list for this setting as the 20 partici-
pating experts were experienced and clinically active PC 
providers.12
Furthermore, in the majority of the European coun-
tries, GPs act as gatekeepers to the healthcare system. In 
countries in which this is not the case, such as in Swit-
zerland, Germany or Greece, where patients can directly 
access specialist care, the prevalence of MM in general 
practice may be lower. Only few studies conducted in such 
countries are reported in the literature. In a predomi-
nantly rural population in Greece, the prevalence of MM 
(≥2 CCs) in PC was 20.0%.13 Yet there was potentially a 
participation bias since GPs participated on invitation 
and worked in specific rural and semirural populations. 
In a German study, 58.9% of patients above the age of 65 
seen in ambulatory settings had three or more CCs.14 Yet 
these findings were based on insurance claims data and 
not limited to patients consulting in PC. In Switzerland, 
one study used electronic data from general practices in 
a German-speaking region and identified a prevalence of 
MM (≥2 CCs) of 13%–15%. Yet there was a high prob-
ability of under-reporting in this study since CCs that 
were not discussed during the consultation were not 
reported.15
In view of these limitations, our aim was to provide esti-
mates of the prevalence of MM in PC in Switzerland, based 
on the list of 75 CCs relevant for MM. We hypothesised 
that this prevalence may be lower in a setting in which 
GPs do not have a gatekeeper role within the health-
care system (as is the case in Switzerland), compared 
with a setting in which patients need to see a GP to be 
referred to a specialist. We also hypothesised that the use 
of a predefined list of CCs relevant to MM in PC would 
provide us with a more precise estimate of the prevalence 
of MM in this setting.
MethOds
Participants and procedure
This cross-sectional study was conducted from 14 
September to 6  November 2015 in general practices 
across Switzerland. We recruited a voluntary sample 
of 118 GPs from the Sentinella network, who collected 
data from 25 consecutive patients attending their prac-
tice during a 2-week period. Sentinella is a representative 
network involving 132 voluntary GPs (and approximately 
30 general paediatricians, not included in this study) 
across Switzerland. The network was initially set up for the 
epidemiological monitoring of infectious diseases. The 
Swiss Federal Office of Public Health (FOPH) runs the 
administrative part of the programme and ensures that 
GPs are included to be overall representative of all GPs 
working in Switzerland, and thus also of 75%–80% of the 
population who visits a GP at least once a year. The Senti-
nella network also participates in selected research proj-
ects. As partner of the network, the FOPH collects data 
from the GPs registered with the network and ensures 
they remain anonymous.
data collection
For our study, participating GPs were asked to preselect a 
day within the 2-week study period on which they began 
data collection for our study. For each patient included 
in the study, participating GPs completed a paper clin-
ical report form (CRF), which included patients’ age 
and gender and CCs, identified from the list of 75 CCs 
(described below).12 The possibility to add relevant CCs 
in free text was left to the GPs, to overcome any limita-
tions due to a selected list of CCs. The CRF was a double-
sided A4 sheet in which the list of CCs was grouped by 
main systems in order to facilitate GPs’ quick identifica-
tion of relevant CCs for each patient, thus limiting poten-
tial omissions.
All data were anonymised and recorded into a 
centralised database. All the written communications 
were made through official letters from the FOPH as 
per the usual communication of the Sentinella network. 
This ensured the anonymity of data because there 
was no contact between the participating GPs and the 
investigators.
We used the list of 75 CCs developed by N’Goran 
et al and recently used in the Multimorbidity in Family 
Medicine study.12 16 This list is based on ICPC-2 and is the 
result of a four-round modified RAND survey involving a 
panel of GPs throughout Switzerland to identify the CCs 
most relevant to MM.17
sample size
We calculated that a sample size of 2016 patients would 
be sufficient to measure a prevalence of MM of around 
30% with a precision margin of 2%. Adapting for the 
clustering of patients within different practices, we used 
an intraclass correlation coefficient of 0.01, based on the 
literature, and estimated a sample size adjusted to 2499, 
rounded off to 2500 for practical purposes.
statistical analyses
A double data entry followed by a reconciliation 
process was used to ensure the quality of the database. 
We performed descriptive analyses using Stata V.13 
(StataCorp). Patients with missing data for age, gender 
and/or CCs were excluded. Continuous data (age) were 
summarised using means and SDs, whereas categor-
ical data were summarised using proportions and CIs, 
adjusted for clustering within practices. We calculated the 
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point prevalence of MM and estimated prevalence of MM 
by age groups (grouped by steps of 20 years) and by sex. 
We also computed the prevalence of each CC individually 
as well as grouped by system.
results
descriptive statistics
Participation rate was high with 118 of 132 eligible GPs 
(89.4%) in the Sentinella network participating in our 
study.
The GPs included 2966 patients. Gender information 
was missing for 54 patients (reported by 29 different GPs) 
and year of birth for 16 patients (from 13 GPs) including 
8 patients for whom both gender and year of birth was 
missing. Furthermore, one patient was excluded because 
of missing data concerning CCs. As a result, 2904 patients 
were retained in the final sample and included in the 
statistical analysis. 43.7% were male and mean (SD) age 
was 56.5 (20.5) years.
The sex and age distribution in our sample was compa-
rable to that of all doctor–patient contacts in the Senti-
nella network during a similar period (data not shown). 
We assumed that the minimal differences (<2%) in the 
proportion of individuals in certain age subgroups did 
not have an influence on the results.
The prevalence of MM independently of age was 52.1% 
for two or more CCs and 35.0% for three or more CCs. 
Considering the total sample, 27% did not have any CCs 
and 1.5% had more than eight CCs. Prevalence of MM was 
equally distributed between females and males. Table 1 
shows details of the prevalence of two, three or more CCs 
by gender and age group. The prevalence of MM defined 
as two or more CCs was 6.2% in those below the age of 
20 years, compared with 44.7%, 71.6% and 85.8% in the 
age groups 41–60 years, 61–80 years and above 80 years, 
respectively (table 1).
As expected, below the age of 20, only a minority of 
patients had a CC (n=624, 21.5%). Between 40 and 60 
years, about 70% had at least one CC, and above the age 
of 80, the proportion of patients without any CCs was 
negligible (figure 1).
distribution by system
The most commonly reported CCs concerned the 
cardiovascular system. Psychological disorders, meta-
bolic and endocrine disorders were also common 
(table 2). The detailed prevalence estimates for all 
conditions are presented in the online supplementary 
table.
CCs which contributed most to MM in the age groups 
0–20 and 20–40 were psychological conditions and meta-
bolic diseases. Cardiovascular conditions were at the 
forefront in patients over the age of 40 even though 
psychological conditions also often contributed to MM in 
these age groups (figure 2). T
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dIsCussIOn
summary of main findings
Our study highlights the high prevalence of MM in a 
nationwide cross-sectional study in PC in Switzerland, 
based on a representative list of CCs relevant for MM. 
Prevalence of two or more CCs across all age groups 
was 52.2%, and prevalence of three or more CCs was 
35.0%. There were no significant gender differences. As 
expected, the prevalence of MM increases with age, with 
about 72% of patients above 60 years of age having at least 
two or more CCs, indicating that MM is common in GPs’ 
daily practice, even in a country in which GPs do not have 
a gatekeeping role within the healthcare system. GPs in 
our study were more frequently in contact with patients 
with one or more CCs than without (73% vs 27%).
The distribution by organ chapter or system highlighted 
the predominance of cardiovascular diseases mainly 
due to elevated or high blood pressure with or without 
complications, which accounted for more than one-third 
of the conditions. Psychological disorders were prevalent 
in all age groups and accounted for nearly 30% of all CCs.
Comparison with the existing literature
Our prevalence estimates are much higher than that 
described in a previous study conducted in Switzerland, 
based on data extracted from electronic medical records, 
in which prevalence of MM was 15% (Family Medicine 
ICPC Research using electronical medical records (FIRE) 
study).15 Under-reporting of CCs not actively treated in 
the consultation may possibly explain the low prevalence 
of MM in this study. Similarly, under-recording in elec-
tronic medical records may explain the lower prevalence 
of MM measured as two or more CCs (23.2%) in another 
study involving more than 300 practices in Scotland.4 In 
addition, in the Scottish study, the CCs were identified 
within a list of 40 conditions established by the authors, 
and were not based on the ICPC-2. Thus, these findings 
are not directly comparable with ours. Studies from the 
Netherlands used lists based on ICPC-2. In a Dutch study 
using a list of 28 CCs within this classification, prevalence 
of MM defined as two or more CCs in patients above 
the age of 55 years was 37%.18 This is surprisingly low 
compared with our findings, particularly if one considers 
that younger patients were excluded. Again, under-re-
porting due to extraction limited to active CCs within 
electronic medical files, may explain this low prevalence 
as well as the limited number of CCs to choose from 
within the list these authors used. A reference group 
outside of Europe (Fortin et al) reported prevalence esti-
mates of two or more CCs of 98.7% in patients above the 
age of 65.5 In this study, no preselected list of CCs was 
used. The practitioners had the possibility of reporting 
any conditions they considered chronic and this may have 
increased the spectrum of disorders potentially contrib-
uting to MM in this study. The same authors reported 
strong differences in estimated prevalence according to 
variations in the methodology of the study, particularly 
with regard to the number of CCs.7 In a recent substudy 
of the national survey Bettering the Evaluation and Care 
of Health in Australia, a prevalence of around 50% for 
two or more CCs and 27% for three or more CCs in a 
family medicine sample was estimated, similar to our 
findings.19
Figure 1 Number of chronic conditions (CCs) by age group in a representative sample of 2904 patients reported by 118 
general practitioners throughout Switzerland, and prevalence of multimorbidity in each age group.
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Unlike in other health systems, GPs in Switzerland 
generally do not have a gatekeeper role and patients can 
have direct access to specialists. We hypothesise that a 
number of patients with only one CC may tend to only 
see a specialist. However, as the complexity of managing 
CCs increases, we can expect that a more holistic manage-
ment will require a GP. Therefore, we hypothesise that 
in the Swiss healthcare system, the more CCs a patient 
has, the more likely it is that they will be managed by a 
GP rather than a specialist. This could lead to a selection 
of patients, in turn resulting in a higher prevalence of 
MM in PC, as observed in our study. Alternatively, patients 
with more CCs may more often require coordination of 
specialised care through the GP.
In our study, prevalence of two or more CCs in the 0–20 
age group was 6.2% and close to 90% in patients above 
80 years old. Thus, MM is associated with age, but not 
gender, which is consistent with others studies.1 5 20
The main CCs reported in the literature are cardio-
vascular diseases, diabetes, chronic kidney disease, 
osteoarthritis, chronic lung diseases, mental disorders 
(depression, dementia).21 Our results are consistent with 
a majority of conditions involving the cardiovascular 
system. However, our prespecified list of chronic disor-
ders did not include disorders such as back and cervical 
pain specifically. GPs could either report the latter as 
general pain or add a commentary at the end of the form. 
Thus, the contribution of these disorders to the overall 
prevalence may have been underestimated.
The prevalence of cardiovascular diseases and endo-
crine and metabolic diseases was 20–40 times higher 
in those above the age of 80 years compared with the 
youngest age group. Psychological disorders were only 
about three times more prevalent in older age groups, 
in line with previous studies reporting high prevalence of 
mental disorders in young persons.22
Table 2 Prevalence of chronic conditions (CCs) in the representative sample of 2904 patients (presenting only CCs with a 
prevalence ≥5% in one gender)
CCs
ICPC-
2 code Male (n=1268) Female (n=1636) Total (n=2904)
% (95% CI) % (95% CI) % (95% CI)
Cardiovascular diseases
  Hypertension 
uncomplicated
K86 20.7 (17.8 to 23.9) 19.4 (16.9 to 22.3) 20.0 (17.6 to 22.6) 
  Elevated blood pressure K85 14.0 (11.2 to 17.3) 10.8 (8.4 to 13.7) 12.2 (9.9 to 14.9) 
  Risk factor cardiovascular 
disease
K22 13.1 (10.3 to 16.5) 10.4 (7.9 to 13.6) 11.6 (9.2 to 14.5) 
  Atrial fibrillation/flutter K78 7.0 (5.6 to 8.8) 6.3 (5.0 to 7.9) 6.6 (5.6 to 7.8) 
  Ischaemic heart disease 
without angina
K76 6.9 (5.5 to 8.7) 3.7 (2.7 to 4.9) 5.1 (4.2 to 6.2) 
  Atherosclerosis K92 6.4 (5.0 to 8.1) 3.7 (2.9 to 4.8) 4.9 (4.1 to 5.8) 
  Cerebrovascular disease K91 5.1 (3.9 to 6.8) 3.0 (2.1 to 4.2) 3.9 (3.1 to 4.9) 
Endocrine/metabolic and nutritional
  Obesity T82 13.6 (11.2 to 16.5) 16.8 (14.1 to 19.9) 15.4 (13.3 to 17.9) 
  Diabetes non-insulin 
dependent
T90 13.0 (11.0 to 15.4) 8.3 (6.8 to 10.1) 10.4 (9.0 to 11.9) 
Psychological
  Depressive disorder P76 9.4 (7.6 to 11.5) 14.9 (13.0 to 17.1) 12.5 (10.9 to 14.3) 
  General and unspecified
  Pain general/multiple 
sites
A01 6.9 (5.3 to 9.0) 10.5 (8.7 to 12.7) 9.0 (7.5 to 10.7) 
Musculoskeletal
  Osteoarthritis of knee L90 6.1 (4.8 to 7.6) 9.4 (7.7 to 11.5) 8.0 (6.7 to 9.4) 
  Osteoarthritis of hip L89 4.4 (3.2 to 6.1) 7.7 (6.2 to 9.5) 6.3 (5.1 to 7.7) 
  Osteoporosis L95 0.9 (0.5 to 1.7) 7.6 (6.2 to 9.3) 4.7 (3.9 to 5.8) 
Respiratory
  Chronic obstructive 
pulmonary disease
R95 5.0 (3.8 to 6.5) 3.6 (2.7 to 4.8) 4.2 (3.4 to 5.1) 
ICPC-2, International Classification for Primary Care, Second edition. 
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strengths and limitations
A main strength of the current study is that our data 
were collected from a representative sample of practices 
throughout an entire country and using a scientifically 
established list of 75 CCs relevant to MM in PC. This list is 
a result of a consensus process between experts in general 
practice to identify the CCs that are most relevant to MM 
in PC.12 It provides an estimate based on the daily reality 
of GPs, and adds strength to the validity of the selected 
list.
Our inclusion criteria did not exclude any age category, 
which enabled us to estimate prevalence among young 
people, contrary to the majority of other studies that have 
only been interested in patients above the age of 50 or 65 
years.
There was no participation bias as every consecutive 
patient was included.
Our study has certain limitations. First, our estimate 
was rather conservative, as reported CCs were prese-
lected. This may have led to an underestimation of MM, 
as it has been suggested that prevalence of MM is highly 
dependent on the number of CCs included in the defi-
nition.11 23 Some GPs added conditions at the end of the 
form if they had not found them in the prespecified list. 
These were too heterogeneous to be counted in the MM 
prevalence estimates, which were thus based exclusively 
on the 75 predefined CCs. Second, some CCs (chronic 
renal failure) were missing from the ICPC-2, and thus 
from our selection. In addition, other CCs, such as 
thyroid diseases, degenerative diseases, chronic hepa-
titis, were not part of our selected list of CCs. Third, we 
used a newly created list of CCs.12 This could compro-
mise the external validity of our study, since no exact 
comparison with previous prevalence studies could be 
done. However, this list was developed specifically for 
PC following a rigorous methodology. Its previous use to 
characterise a sample of multimorbid patients  in PC led 
to similar distributions of CCs (although as this previous 
study involved only multimorbid patients, no prevalence 
data could be extracted).16 GPs from all parts of Switzer-
land, practising in three culturally diverse regions of the 
country, were involved in the development of this list. 
Since the epidemiological profile of MM is likely to be 
similar in other high-income countries, the list is likely 
to be relevant for studies in most other high-income 
countries.
Fourth, the definition of CCs such as elevated blood 
pressure was left to the appreciation of GPs and CCs 
such as cardiovascular risk factors may be redundant with 
obesity, high blood pressure or tobacco use. In addition, 
GPs who were not familiar with ICPC-2 codes may have 
miscoded some items, thus leading to reporting bias. In 
particular, we cannot exclude that some GPs may have 
recorded family history or age, as a cardiovascular risk 
factor. Fifth, we cannot differentiate whether reported 
CCs were active health problems or not. GPs may have 
reported important CCs which no longer had an impact 
on the patient’s current health, such as cancer treated in 
the past. Finally, that no general paediatricians (who are 
PC providers in Switzerland) participated in our study 
may have led to an underestimation of the prevalence of 
MM in the age group 0–20 years old.
Figure 2 Spread across systems of chronic conditions contributing to multimorbidity, by age group, in 2904 primary care 
patients.
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Implications for practice and research
Our findings highlight that even in a country in which GPs 
do not have a gatekeeping role, caring for patients with 
MM is at the forefront of their activity. In the context of a 
high prevalence of MM as estimated in our study, disease-
based management is no longer possible and developing 
new models of care is essential. This has implications for 
service planning (including thoughts about pricing) and 
for pregraduate and postgraduate training.
A fundamental concept is the global impact of MM 
on quality of care, and complexity of care, that could be 
more accurately assessed by a validated morbidity index 
rather than by adding CCs together. Future studies need 
to specify which combination of CCs or patients’ charac-
teristics are associated with higher needs and impacts on 
quality of care, morbidity and mortality. This could help 
us identify subgroups of patients who could benefit the 
most from new models of care.
COnClusIOns
MM is highly prevalent among patients consulting GPs in 
Switzerland. These results have implications for training 
and the organisation of healthcare in our country. The 
identification of the patients most likely to benefit from 
complex care within family practice, and the develop-
ment of new models of care to address their needs are 
challenges for the future.
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